Showing 1 - 20 results of 24 for search '"электроимпульсная терапия"', query time: 0.68s Refine Results
  1. 1
    Academic Journal

    Contributors: The authors declare no funding for this study, Авторы заявляют об отсутствии финансирования при проведении исследования

    Source: The Russian Archives of Internal Medicine; Том 14, № 6 (2024); 467-472 ; Архивъ внутренней медицины; Том 14, № 6 (2024); 467-472 ; 2411-6564 ; 2226-6704

    File Description: application/pdf

    Relation: https://www.medarhive.ru/jour/article/view/1883/1372; https://www.medarhive.ru/jour/article/view/1883/1379; Thangjui S., Thyagaturu H., Trongtorsak A., et al. Electrical Cardioversion-Associated Takotsubo Cardiomyopathy: A National Readmission Database 2018 Analysis and Systematic Review. Anatol J Cardiol. 2023; 27(2): 62-68. DOI:10.14744/AnatolJCardiol.2022.2236; El-Battrawy I., Cammann V.L., Kato K., et al. Impact of Atrial Fibrillation on Outcome in Takotsubo Syndrome: Data From the International Takotsubo Registry. J Am Heart Assoc. 2021; 10(15): e014059. DOI:10.1161/JAHA.119.014059; Аракелян М.Г., Бокерия Л.А., Васильева Е.Ю. и др. Фибрилляция и трепетание предсердий. Клинические рекомендации 2020. Российский кардиологический журнал. 2021; 26(7): 4594. DOI:10.15829/1560-4071-2021-4594; Болдуева С.А., Евдокимов Д.С. Кардиомиопатия такоцубо. Обзор данных литературы: понятие, эпидемиология, патогенез. Часть I. Российский кардиологический журнал. 2022; 27(3S): 4993. DOI:10.15829/1560-4071-2022-4993; Ghadri J.R., Wittstein I.S., Prasad A., et al. International Expert Consensus Document on Takotsubo Syndrome (Part I): Clinical Characteristics, Diagnostic Criteria, and Pathophysiology. Eur. Heart J. 2018; 39: 2032-46. DOI:10.1093/eurheartj/ehy076; Болдуева С.А., Феоктистова В.С., Евдокимов Д.С. и др. Клинический случай синдрома такоцубо в раннем послеоперационном периоде ринопластики. Архивъ внутренней медицины. 2022; 12(4): 316-320. DOI:10.20514/2226-6704-2022-12-4-316-320; Bae J.Y., Tartaglia J., Chen M., Setaro J.F. Direct current cardioversion-triggered atypical Tako-tsubo cardiomyopathy : a case report and review of literature. Eur Heart J Case Rep. 2022; 6(2): ytac045. DOI:10.1093/ehjcr/ytac045; Bairashevskaia A.V., Belogubova S.Y., Kondratiuk M.R., et al. Update of Takotsubo cardiomyopathy: Present experience and outlook for the future. Int J Cardiol Heart Vasc. 2022; 39: 100990. DOI:10.1016/j.ijcha.2022.100990; Li P., Wang Y., Liang J., et al. Takotsubo syndrome and respiratory diseases : a systematic review. Eur Heart J Open. 2022; 2(2): oeac009. DOI:10.1093/ehjopen/oeac009; Lu X., Li P., Teng C., et al. Prognostic factors of Takotsubo cardiomyopathy : a systematic review. ESC Heart Fail. 2021; 8(5): 3663-3689. DOI:10.1002/ehf2.13531; https://www.medarhive.ru/jour/article/view/1883

  2. 2
    Academic Journal

    Source: Obstetrics, Gynecology and Reproduction; Vol 15, No 4 (2021); 419-429 ; Акушерство, Гинекология и Репродукция; Vol 15, No 4 (2021); 419-429 ; 2500-3194 ; 2313-7347

    File Description: application/pdf

    Relation: https://www.gynecology.su/jour/article/view/1070/934; Knotts R.J., Garan H. Cardiac arrhythmias in pregnancy. Semin Perinatol. 2014;38(5):285-8. https://doi.org/10.1053/j.semperi.2014.04.017.; Sanghavi M., Rutherford J.D. Cardiovascular physiology of pregnancy. Circulation. 2014;130:1003-8. https://doi.org/10.1161/CIRCULATIONAHA.114.009029.; Trappe H.-J. Cardiac arrhythmias in the pregnant woman and the foetus. European Cardiology. 2008;4(2):67-71. http://dx.doi.org/10.15420/ecr.2008.4.2.67.; Emmanuel Y., Thorne S.A. Heart disease in pregnancy. Best Pract Res Clin Obstet Gynaecol. 2015; 29(5):579-97. https://doi.org/10.1016/j.bpobgyn.2015.04.002.; Абдрахманова А.И., Маянская С.Д, Средюк И.Л. Нарушение сердечного ритма у беременных. Практическая медицина. 2012;(9):45-51.; Silversides C.K., Grewal J., Mason J. et al. Pregnancy outcomes in women with heart disease: the CARPREG II study. J Am Coll Cardiol. 2018;71(21):2419-30. https://doi.org/10.1016/j.jacc.2018.02.076.; Schmidt C., Kisselbach J., Schweizer P.A. et al. The pathology and treatment of cardiac arrhythmias: focus on atrial fibrillation. Vasc Health Risk Manag. 2011;7:193-202. https://doi.org/10.2147/VHRM.S10758.; Gandhi M., Martin S.R. Cardiac disease in pregnancy. Obstet Gynecol Clin North Am. 2015;42(2):315-33. https://doi.org/10.1016/j.ogc.2015.01.012.; Bartos D.C., Grandi E., Ripplinger C.M. Ion channels in the heart. Compr Physiol. 2015;5(3):1423-64. https://doi.org/10.1002/cphy.c140069.; Sedmera D., Kockova R., Vostarek F., Raddatz E. Arrhythmias in the developing heart. Acta Physiol (Oxf). 2015;213(2):303-20. https://doi.org/10.1111/apha.12418.; Mendelsohn M.E., Karas R.H. Molecular and cellular basis of cardiovascular gender differences. Science. 2005;308(5728):1583-7. https://doi.org/10.1126/science.1112062.; Burke J., Goldberger J., Ehlert F.A. et al. Gender differences in heart rate before and after autonomic blockade: evidence against an intrinsic gender effect. Am J Med. 1996;100(5):537-43. https://doi.org/10.1016/s0002-9343(96)00018-6.; Ehdaie A., Cingolani E., Shehata M. et al. Sex differences in cardiac arrhythmias. Circ Arrhythm Electrophysiol. 2018;11(3):e005680. https://doi.org/10.1161/CIRCEP.117.005680.; Curtis A.B., Narasimha D. Arrhythmias in women. Clin Cardiol. 2012;35(3):166-71. https://doi.org/10.1002/clc.21975.; Magnani J.W., Moser C.B, Murabito J.M. et al. Association of sex hormones, aging, and atrial fibrillation in men: the Framingham Heart Study. Circ Arrhythm Electrophysiol. 2014;7(2):307-12. https://doi.org/10.1161/CIRCEP.113.001322.; Locati E.H., Zareba W., Moss A.J. et al. Age- and sex-related differences in clinical manifestations in patients with congenital long-QT syndrome: findings from the International LQTS Registry. Circulation. 1998;97(22):2237-44. https://doi.org/10.1161/01.CIR.97.22.2237.; Gowd P., Thompson P.D. Effect of female sex on cardiac arrhythmias. Cardiol Rev. 2012;20(6):297-303. https://doi.org/10.1097/CRD.0b013e318259294b.; Nowak B., Misselwitz B., Expert committee 'Pacemaker', Institute of Quality Assurance Hessen et al. Do gender differences exist in pacemaker implantation? - results of an obligatory external quality control program. Europace. 2010; 12(2):250-5. https://doi.org/10.1093/europace/eup312.; Zylla M.M., Brachmann J., Lewalter T. et al. Sex-related outcome of atrial fibrillation ablation: insights from the German Ablation Registry. Heart Rhythm. 2016;13:1837-44. https://doi.org/10.1016/j.hrthm.2016.06.005; Westerman S., Wenger N. Gender differences in atrial fibrillation: a review of epidemiology, management, and outcomes. Curr Cardiol Rev. 2019;15(2):136-44. https://doi.org/10.2174/1573403X15666181205110624.; Burke J.H, Ehlert F.A., Kruse J.T. et al. Gender-specific differences in the QT interval and the effect of autonomic tone and menstrual cycle in healthy adults. Am J Cardiol. 1997;79(2):178-81. https://doi.org/10.1016/s0002-9149(96)00707-2.; Kurisu S., Kato Y., Mitsuba N. et al. Gender difference in QT interval in patients with primary aldosteronism. J Renin-Angiotensin-Aldosterone Syst. 2012;13(4):435-9. https://doi.org/10.1177/1470320312447651.; Ravens U. Sex differences in cardiac electrophysiology. Can J Physiol Pharmacol. 2018;96(10):985-90. https://doi.org/10.1139/cjpp-2018-0179.; Noyola-Martinez N., Halhali A., Barrera D. Steroid hormones and pregnancy. Gynecol Endocrinol. 2019;35(5):376-84. https://doi.org/10.1080/09513590.2018.1564742.; Kuijper E.A., Ket J.C., Caanen M.R., Lambalk C.B. Reproductive hormone concentrations in pregnancy and neonates: a systematic review. Reprod Biomed Online. 2013;27(1):33-63. https://doi.org/10.1016/j.rbmo.2013.03.009.; Adamson D.L., Nelson-Piercy C. Managing palpitations and arrhythmias during pregnancy. Heart. 2007;93(12):1630-6. https://doi.org/10.1136/hrt.2006.098822.; Silversides C.K., Harris L., Haberer K. et al. Recurrence rates of arrhythmias during pregnancy in women with previous tachyarrhythmia and impact on fetal and neonatal outcomes. Am J Cardiol. 2006;97:1206-12. https://doi.org/10.1016/j.amjcard.2005.11.041.; Nanda S., Nelson-Piercy C., Mackillop L. Cardiac disease in pregnancy. Clin Med (Lond). 2012;12(6):553-60. https://doi.org/10.7861/clinmedicine.12-6-553.; Afanasiuk O.I, Shmaliy V.I, Shushkovska Y.Y. Clinical characteristics of cardiac arrhythmias in pregnant women. Wiad Lek. 2019;72(3):381-83.; Enriquez A.D., Economy K.E., Tedrow U.B. Contemporary management of arrhythmias during pregnancy. Circ Arrhythm Electrophysiol. 2014;7(5):961-7. https://doi.org/10.1161/CIRCEP.114.001517.; Тереховская Ю.В., Смирнова Е.А. Нарушения ритма сердца у беременных. Наука молодых (Eruditio Juvenium). 2017;5(3):462-80. https://doi.org/10.23888/hmj20173462-480.; Wright J.M., Page R.L., Field M.E. Antiarrhythmic drugs in pregnancy. Expert Rev Cardiovasc Ther. 2015;13(12):1433-44. https://doi.org/10.1586/14779072.2015.1107476.; Roos-Hesselink J., Baris L., Johnson M. et al. Pregnancy outcomes in women with cardiovascular disease: evolving trends over 10 years in the ESC Registry Of Pregnancy And Cardiac disease (ROPAC). Eur Heart J. 2019;40(47):3848-55. https://doi.org/10.1093/eurheartj/ehz136.; Yaksh A., van der Does L.J., Lanters E.A., de Groot N.M. Pharmacological therapy of tachyarrhythmias during pregnancy. Arrhythm Electrophysiol Rev. 2016;5(1):41-4. https://doi.org/10.15420/AER.2016.1.2.; Regitz-Zagrosek V., Roos-Hesselink J.W., Bauersachs J. et al. 2018 ESC Guidelines on the management of cardiovascular diseases during pregnancy. Eur Heart J. 2018;39:3165-241. https://doi.org/10.1093/eurheartj/ehy340.; Laksman Z., Harris L., Silversides C.K. Cardiac arrhythmias during pregnancy: a clinical approach. Fetal and Maternal Medicine Review. 2011;22(02):123-43. https://doi.org/10.1017/S0965539511000076.; Hsu J.C., Maddox T.M., Kennedy K. et al. Aspirin instead of oral anticoagulant prescription in atrial fibrillation patients at risk for stroke. J Am Coll Cardiol. 2016;67:2913-23. https://doi.org/10.1016/j.jacc.2016.03.581.; Chauveau S., Le Vavasseur O., Morel E. et al. Flecainide is a safe and effective treatment for pre-excited atrial fibrillation rapidly conducted to the ventricle in pregnant women: a case series. Eur Heart J Case Rep. 2019;3(2):ytz066. https://doi.org/10.1093/ehjcr/ytz066.; Goland S., Elkayam U. Anticoagulation in pregnancy. Cardiol Clin. 2012;30(3):395-405. https://doi.org/10.1016/j.ccl.2012.05.003.; Ferreira N.S., La Croix Barros T., Gismondi R.A. Supine frequent ventricular extrasystoles in a pregnant woman without structuralh Heart disease. Case Rep Med. 2016;2016:1-3. https://doi.org/10.1155/2016/6213198.; Wright J.M., Page R.L., Field M.E. Antiarrhythmic drugs in pregnancy. Expert Rev Cardiovasc Ther. 2015;13(12):1433-4. https://doi.org/10.1586/14779072.2015.1107476.; Gowda R.M., Khan I.A., Mehta N.J. et al. Cardiac arrhythmias in pregnancy: clinical and therapeutic considerations. Int J Cardiol. 2003;88(2-3):129-133. https://doi.org/10.1016/s0167-5273(02)00601-0.; Uzun O., Babaoglu K., Sinha A. et al. Rapid control of foetal supraventricular tachycardia with digoxin and flecainide combination treatment. Cardiol Young. 2012;22(4):372-80. https://doi.org/10.1017/S1047951111001272.; Trappe H.J. Emergency therapy of maternal and fetal arrhythmias during pregnancy. J Emerg Trauma Shock. 2010;3(2):153-9. https://doi.org/10.4103/0974-2700.62116.; https://www.gynecology.su/jour/article/view/1070

  3. 3
    Academic Journal

    Source: Rational Pharmacotherapy in Cardiology; Vol 14, No 4 (2018); 605-611 ; Рациональная Фармакотерапия в Кардиологии; Vol 14, No 4 (2018); 605-611 ; 2225-3653 ; 1819-6446 ; 10.20996/1819-6446-2018-14-4

    File Description: application/pdf

    Relation: https://www.rpcardio.com/jour/article/view/1732/1698; 2017 ESC guidelines for the management of acute myocardial infarction in patients presenting withST-segment elevation. Eur Heart J. 2018;39:119-77. doi:10.1093/eurheartj/ehx393.; Schmitt J., Duray G., Gersh B.J., Hohnloser S.H. Atrial fibrillation in acute myocardial infarction. Eur Heart J. 2009;30:1038-45. doi:10.1093/eurheartj/ehn579.; Jabre P., Jouven X., Adnet F. et al. Atrial fibrillation and death аfter myocardial infarction: a community study. Circulation. 2011;123:2094-100. doi:10.1161/CIRCULATIONAHA.110.990192.; Jabre P., Roder V.L., Murad M.H. et al. Mortality associated with atrial fibrillation in patients with myocardial infarction. Circulation. 2011;123:1587-93. doi.org/10.1161/CIRCULATIONAHA. 110.986661.; Crenshow B.S., Ward S.R., Granger C.B. et al. Atrial fibrillation in the setting of acute myocardial infarction. J Am Coll Cardiol. 1997;30:406-13.; Cardiac arrhythmias in acute coronary syndromes: position paper from the joint EHRA, ACCA and EAPCI task force. Europace. 2014;16:1655-673. doi:10.1093/europace/euu208.; 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation. J. Am. Coll. Cardiol. 2014;64(21):e1-e76. doi:10.1016/j.jacc.2014.03.022.; 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS. Eur Heart J. 2018;39(3):213-60. doi.org/10.1093/eurheartj/ehx419.; Risius T., Mortensen K., Schwermer T.F. et al.Comparison of anterio-lateral versus anterio-posterior electrode position for biphasic external cardioversion of atrial flutter. Am J Cardiol. 2009;104:154750. doi:10.1016/j.amjcard.2009.07.027.; Manegold J.C., Israel C.W., Ehrlich J.R. et al. External cardioversion of atrial fibrillation in patients with implanted pacemaker or cardioverter-defibrillator. Eur Heart J. 2007;28:1731-8. doi:10.1093/eurheartj/ehm211.; Priori S.G., Blomstrom-Lundgvist C., Mazzanti A. et al. 2015 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur. Heart J. 2015;36:2793-867. doi:10.1093/europace/euv319.; Piccini J.P., Schulte P.J., Pieper K.S. et al. Antiarrhythmic drug therapy for sustained ventricular arrhythmias complicating acute myocardial infarction. Crit Care Med. 2011;39:78-83. doi:10.1097/CCM.0b013e3181fd6ad7.; He X.Z., Zhou S.H., Wan X.H. et al. The effect early and intensive statin therapy on ventricular premature beat or nonsustained ventricular tachycardia in patients with acute coronary syndrome. Clin Cardiol. 2011;34:59-63. doi:10.1002/clc.20818.; 2015 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J. 2015;36(41):2793-867. doi:10.1093/eurheartj/ ehv316.; 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction. Circulation. 2013;127:e362-e425. doi:10.1161/CIR.0b013e3182742cf6.; Cardiac Arrhythmia Suppression Trial (CAST) investigators. Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med. 1989;321(6):406-12. doi:10.1056/NEJM198908103210629.; The cardiac arrhythmia suppression trial II investigators. Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction. N Engl J Med. 1992;327(4):227-33. doi:10.1056/NEJM199207233270403.; Teo K.K., Yusuf S., Furberg C.D. Effects prophylactic antiarrhythmic drug therapy in acute myocardial infarction. JAMA. 1993;270(13):1589-95.; Antman E.M. ST-elevation myocardial infarction: management. In Braunwald E., Zipes L., Libby P., Bonow R. (eds). Heart disease. Philadelphia: W.B. Saunders company; 2005. P.1167-1226.; Бунин Ю.А. Возможности антиаритмической терапии в первичной профилактике смерти у больных с желудочковыми аритмиями. Рациональная Фармакотерапия в Кардиологии. 2010;6(6):870-5. doi:10.20996/1819-6446-2010-6-6-870-875.; Bardy G.H., Lee K.L., Mark D.B. et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005;352:225-37. doi:10.1056/NEJMoa043399.; Boutitie F., Boissel J.P., Connoly S.J. et al. Amiodarone interaction with beta-blokers: analysis of the merged EMIAT and CAMIAT detabases. Circulation. 1999;99:2268-75. doi:10.1161/01.CIR. 99.17.2268.; 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. ACC (2017). J Am Coll Cardiol. 2017 Oct 25. pii: S07351097(17)41306-4. doi:10.1016/j.jacc.2017.10.054.; https://www.rpcardio.com/jour/article/view/1732

  4. 4
  5. 5
    Academic Journal

    Source: PULMONOLOGIYA; № 2 (2013); 52-56 ; Пульмонология; № 2 (2013); 52-56 ; 2541-9617 ; 0869-0189 ; 10.18093/0869-0189-2013-0-2

    File Description: application/pdf

    Relation: https://journal.pulmonology.ru/pulm/article/view/163/159; Ciencewicki J., Trivedi S., Kleeberger S.R. Oxidants and the pathogenesis of lung diseases. J. Allergy Clin. Immunol. 2008; 122 (3): 456–468.; Dozor A.J. The role of oxidative stress in the pathogenesis and treatment of asthma. Ann. N.Y. Acad. Sci. 2010; 1203: 133–137.; Chung K.F., Marwick J.A. Molecular mechanisms of oxidative stress in airways and lungs with reference to asthma and chronic obstructive pulmonary disease. Ann. N.Y. Acad. Sci. 2010; 1203: 85–91.; Cho Y.S., Moon H.B. The role of oxidative stress in the pathogenesis of asthma. Allergy Asthma Immunol. Res. 2010; 2 (3): 183–187.; Malling T.H., Sigsgaard T., Andersen H.R. et al. Differences in associations between markers of antioxidative defense and asthma are sex specific. Gend. Med. 2010; 7 (2): 115–124.; Глобальная стратегия лечения и профилактики бронхиальной астмы (пересмотр 2007 г.): Пер. с англ. под ред. А.Г.Чучалина. М.: Издат. дом "Атмосфера"; 2008.; Чучалин А.Г. Респираторная медицина. М.: ГЕОТАР-Медиа; 2007; т. 1.; Miller M.R., Hankinson J., Brusasco V. et al. ATS / ERS Task Force. Standardisation of spirometry. Eur. Respir. J. 2005; 26 (2): 319–338.; Чучалин А.Г. (ред.). Функциональная диагностика в пульмонологии: Практ. руководство. М.: Издат. Холдинг "Атмосфера"; 2009.; Стальная И.Д., Горишвили Т.Д. Метод определения малонового диальдегида с помощью тиобарбитуровой кислоты. В кн.: Современные методы в биохимии. М.: Медицина; 1977. 66–68.; Стальная И.Д. Метод определения диеновой конъюгации ненасыщенных кислот. В кн.: Современные методы в биохимии. М.: Медицина; 1977. 63–64.; Bidlack W.R., Dyel A.L. Damage of microsomal membrane by lipid peroxidation. Lipids 1959; 8 (4): 177–182.; Fried R. Enzymatic and non- enzymatic assay of superoxide dismutase. Biochemistry 1975; 87: 657–666.; Minami M., Yoshikama H. A simplified method of superoxide dismutase activity for clinical use. Clin. Chim. Acta. 1979; 92 (3): 337–342.; Колб В.Г., Камышников В.С. Справочник по клинической химии. Минск: Беларусь; 1982.; Bligh E., Dyer W.J. Rapid method of total lipid extraction fined purification. Can. Biochem. Physiol. 1959; 37 (8): 911–912.; Владимиров Ю.А., Добрецова Г.В. Флуоресцентные зонды в исследовании биологических мембран. М.: Наука; 1980.; Гринберг Я.З. СКЭНАР – построение, физические механизмы, основные эффекты. Нелекарств. мед. 2006; 3: 37–42.; Гуляев В.Ю., Щеколдин П.И., Чернышов В.В. Лечебное применение импульсов низкочастотной терапии. Урал. мед. обзоры 2001; 2: 47–54.; Гринберг Я.З. СКЭНАР-терапия и СКЭНАР-экспертиза – некоторые аспекты. Рефлексология 2005; 3 (7): 5–10.; https://journal.pulmonology.ru/pulm/article/view/163

  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
    Dissertation/ Thesis

    Contributors: Барац, С. С.

    Subject Geographic: RSFSR, SGMI, РСФСР, СГМИ

    File Description: application/pdf

    Relation: Андреев, А. Н. Немедикаментозная терапия стенокардии : диссертация … доктора медицинских наук : 14.00.06 / Андреев Аркадий Николаевич. – Свердловск, 1991. – 350 с. – Текст электронный; http://elib.usma.ru/handle/usma/20081